Skip to main content
Premium Trial:

Request an Annual Quote

Clinical Data Shares Rise 8 Percent in Advance of Stock Split

NEW YORK (GenomeWeb News) - Clinical Data's share price climbed 8 percent to $39 a share in late-morning trading today, reaching a new 52-week high.
 
Earlier this month, the company authorized a 3-for-2 stock split for shareholders of record as of Sept. 24. The new shares will be distributed Oct. 1.
 
Clinical Data’s shares are up more than 12 percent for the week beginning Sept. 24.
 
The company’s shares were trading at $38.85 in the mid-afternoon.
The Scan

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.

TB Resistance Insights Gleaned From Genome Sequence, Antimicrobial Response Assays

Researchers in PLOS Biology explore M. tuberculosis resistance with a combination of sequencing and assays looking at the minimum inhibitory concentrations of 13 drugs.

Mendelian Disease Genes Prioritized Using Tissue-Specific Expression Clues

Mendelian gene candidates could be flagged for further functional analyses based on tissue-specific transcriptome and proteome profiles, a new Journal of Human Genetics paper says.

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.